We promote the understanding of assessment and access processes for life science products to support the development and adoption of innovative treatments
The Italian Medicines Agency AIFA has formalised a simplified and a fast-track accelerated negotiation route to shorten the timeline for pricing and reimbursement decisions.
The Danish Medicines Agency DKMA has launched a formal consultation to reassess the general reimbursement status of a broad range of oncology treatments.
